Advertisement Novo Nordisk Pharmatech Opens First Branch Office in Singapore - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More

Novo Nordisk Pharmatech A/S

Supplier of Quaternary Ammonium Compounds and Recombinant Insulin Human AF

Novo Nordisk Pharmatech Opens First Branch Office in Singapore

The grand opening of Novo Nordisk Pharmatech A/S new branch office in Singapore on October 15 was celebrated together with customers, employees and other stakeholders.

Novo Nordisk Pharmatech A/S managing director and corporate vice-president Rasmus Hother le Fevre was very proud and honored to officially announce the opening of a new branch in Singapore located at 152 Beach Road #17-04 The Gateway East with a grand opening celebration on October 15. The Singapore location marks the first branch office for Novo Nordisk Pharmatech which celebrated its 70th anniversary this January.

“We are thrilled to be expanding our footprint into Asia,” said Rasmus Hother le Fevre.

“This new office will serve as a hub to expand our business in Asia and it is in close proximity to some of the world’s leading biopharmaceutical companies. The location will give us access to a very large pool of the biopharmaceutical development in the region which is a key focus of the company.

“Our new Singapore location extends Novo Nordisk Pharmatech’s heritage of delivering high quality quaternary ammonium compounds as well as recombinant insulin for cell culture media to the pharmaceutical and biopharmaceutical industry.

 “A local Singapore branch office was a logical step in our business growth strategy and presents a unique opportunity for Novo Nordisk Pharmatech to strengthen our presence. We have been active in this thriving market for several years. The local office in Singapore will allow us to serve both local companies in Singapore as well the rest of the Asian markets much more efficiently.”